Table of Contents
Physiology Journal
Volume 2015, Article ID 208485, 10 pages
http://dx.doi.org/10.1155/2015/208485
Research Article

The Potential Role of Hemopexin and Heme Oxygenase-1 Inducer in a Model of Sepsis

Department of Medical Physiology, Faculty of Medicine, Alexandria University, Alexandria, Egypt

Received 27 June 2015; Revised 17 August 2015; Accepted 23 August 2015

Academic Editor: Viswanathan Natarajan

Copyright © 2015 Passainte S. Hassaan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. S. Hotchkiss and I. E. Karl, “The pathophysiology and treatment of sepsis,” The New England Journal of Medicine, vol. 348, no. 2, pp. 138–150, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Satran and Y. Almog, “The coagulopathy of sepsis: pathophysiology and management,” Israel Medical Association Journal, vol. 5, no. 7, pp. 516–520, 2003. View at Google Scholar · View at Scopus
  3. J. Cohen, “The immunopathogenesis of sepsis,” Nature, vol. 420, no. 6917, pp. 885–891, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Larsen, R. Gozzelino, V. Jeney et al., “A central role for free heme in the pathogenesis of severe sepsis,” Science Translational Medicine, vol. 2, no. 51, Article ID 51ra71, pp. 51–71, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Fei, X. Meng, M. Zhao et al., “Enhanced induction of heme oxygenase-1 suppresses thrombus formation and affects the protein C system in sepsis,” Translational Research, vol. 159, no. 2, pp. 99–109, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. S. W. Chung, X. Liu, A. A. Macias, R. M. Baron, and M. A. Perrella, “Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice,” The Journal of Clinical Investigation, vol. 118, no. 1, pp. 239–247, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. Y.-T. Lin, Y.-H. Chen, Y.-H. Yang et al., “Heme oxygenase-1 suppresses the infiltration of neutrophils in rat liver during sepsis through inactivation of p38 MAPK,” Shock, vol. 34, no. 6, pp. 615–621, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. K. S. Helmer, J. W. Suliburk, and D. W. Mercer, “Ketamine-induced gastroprotection during endotoxemia: role of heme-oxygenase-1,” Digestive Diseases and Sciences, vol. 51, no. 9, pp. 1571–1581, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. V. Hvidberg, M. B. Maniecki, C. Jacobsen, P. Højrup, H. J. Møller, and S. K. Moestrup, “Identification of the receptor scavenging hemopexin-heme complexes,” Blood, vol. 106, no. 7, pp. 2572–2579, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Tolosano, S. Fagoonee, N. Morello, F. Vinchi, and V. Fiorito, “Heme scavenging and the other facets of hemopexin,” Antioxidants and Redox Signaling, vol. 12, no. 2, pp. 305–320, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. W. W. Bakker, B. N. Melgert, and M. M. Faas, “Hemopexin: anti-inflammatory, pro-inflammatory, or both?” Journal of Leukocyte Biology, vol. 87, no. 1, pp. 1–2, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Liang, T. Lin, G. Sun, L. Beasley-Topliffe, J.-M. Cavaillon, and H. S. Warren, “Hemopexin down-regulates LPS-induced proinflammatory cytokines from macrophages,” Journal of Leukocyte Biology, vol. 86, no. 2, pp. 229–235, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Rittirsch, M. S. Huber-Lang, M. A. Flierl, and P. A. Ward, “Immunodesign of experimental sepsis by cecal ligation and puncture,” Nature Protocols, vol. 4, no. 1, pp. 31–36, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Spiller, C. Costa, F. O. Souto et al., “Inhibition of neutrophil migration by hemopexin leads to increased mortality due to sepsis in mice,” The American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 7, pp. 922–931, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Kitchen and F. E. Preston, “Standardization of prothrombin time for laboratory control of oral anticoagulant therapy,” Seminars in Thrombosis and Hemostasis, vol. 25, no. 1, pp. 17–26, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. C.-E. H. Dempfle, S. Lorenz, M. Smolinski et al., “Utility of activated partial thromboplastin time waveform analysis for identification of sepsis and overt disseminated intravascular coagulation in patients admitted to a surgical intensive care unit,” Critical Care Medicine, vol. 32, no. 2, pp. 520–524, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Nishioka, M. Ning, T. Hayashi, and K. Suzuki, “Protein C inhibitor secreted from activated platelets efficiently inhibits activated protein C on phosphatidylethanolamine of platelet membrane and microvesicles,” The Journal of Biological Chemistry, vol. 273, no. 18, pp. 11281–11287, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Saeki, T. Matsuura, M. Hayashida, and T. Taguchi, “Ischemic preconditioning and remote ischemic preconditioning have protective effect against cold ischemia-reperfusion injury of rat small intestine,” Pediatric Surgery International, vol. 27, no. 8, pp. 857–862, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. S. H. Opdal, “IL-10 gene polymorphisms in infectious disease and SIDS,” FEMS Immunology and Medical Microbiology, vol. 42, no. 1, pp. 48–52, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. Z. Franks, M. Carlisle, and M. T. Rondina, “Current challenges in understanding immune cell functions during septic syndromes,” BMC Immunology, vol. 16, no. 1, article 11, 2015. View at Publisher · View at Google Scholar
  21. D. C. Angus, “The search for effective therapy for sepsis: back to the drawing board?” The Journal of the American Medical Association, vol. 306, no. 23, pp. 2614–2615, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Cohen, S. Opal, and T. Calandra, “Sepsis studies need new direction,” The Lancet Infectious Diseases, vol. 12, no. 7, pp. 503–505, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. W. C. Aird, “The hematologic system as a marker of organ dysfunction in sepsis,” Mayo Clinic Proceedings, vol. 78, no. 7, pp. 869–881, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Zhao, K. Kang, C. Nan et al., “Heme oxygenase 1 modulates thrombomodulin and endothelial protein C receptor levels to attenuate septic kidney injury,” Shock, vol. 40, no. 2, pp. 136–143, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Panwar, B. Venkatesh, P. Kruger et al., “Plasma protein C levels in immunocompromised septic patients are significantly lower than immunocompetent septic patients: a prospective cohort study,” Journal of Hematology & Oncology, vol. 2, article 43, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. K. L. Moore, S. P. Andreoli, N. L. Esmon, C. T. Esmon, and N. U. Bang, “Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro,” The Journal of Clinical Investigation, vol. 79, no. 1, pp. 124–130, 1987. View at Publisher · View at Google Scholar · View at Scopus
  27. C. T. Esmon, J.-M. Gu, J. Xu, D. Qu, D. J. Stearns-Kurosawa, and S. Kurosawa, “Regulation and functions of the protein C anticoagulant pathway,” Haematologica, vol. 84, no. 4, pp. 363–368, 1999. View at Google Scholar · View at Scopus
  28. D. T. Berg, B. Gerlitz, G. R. Sharma et al., “FoxA2 involvement in suppression of protein C, an outcome predictor in experimental sepsis,” Clinical and Vaccine Immunology, vol. 13, no. 3, pp. 426–432, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. P. P. Sarangi, H.-W. Lee, and M. Kim, “Activated protein C action in inflammation,” British Journal of Haematology, vol. 148, no. 6, pp. 817–833, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Bortscher, J. Chang, T. O. Vilz et al., “Hemin induction of HO-1 protects against LPS-induced septic ileus,” Journal of Surgical Research, vol. 178, no. 2, pp. 866–873, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Iwasashi, M. Suzuki, M. Unno et al., “Inhibition of heme oxygenase ameliorates sepsis-induced liver dysfunction in rats,” Surgery Today, vol. 33, no. 1, pp. 30–38, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Suzuki, T. Takahashi, A. Yamasaki, T. Fujiwara, M. Hirakawa, and R. Akagi, “Tissue-specific gene expression of heme oxygenase-1 (HO-1) and non-specific δ-aminolevulinate synthase (ALAS-N) in a rat model of septic multiple organ dysfunction syndrome,” Biochemical Pharmacology, vol. 60, no. 2, pp. 275–283, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. G. S. Supinski and L. A. Callahan, “Hemin prevents cardiac and diaphragm mitochondrial dysfunction in sepsis,” Free Radical Biology & Medicine, vol. 40, no. 1, pp. 127–137, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Tsoyi, T. Y. Lee, Y. S. Lee et al., “Heme-oxygenase-1 induction and carbon monoxide-releasing molecule inhibit lipopolysaccharide (LPS)-induced high-mobility group box 1 release in vitro and improve survival of mice in LPS- and cecal ligation and puncture-induced sepsis model in vivo,” Molecular Pharmacology, vol. 76, no. 1, pp. 173–182, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Freitas, J. C. Alves-Filho, S. C. Trevelin et al., “Divergent role of hemeoxygenase inhibition in the pathogenesis of sepsis,” Shock, vol. 35, pp. 550–559, 2011. View at Google Scholar
  36. T.-Y. Chuang, H.-T. Chang, K.-P. Chung et al., “High levels of serum macrophage migration inhibitory factor and interleukin 10 are associated with a rapidly fatal outcome in patients with severe sepsis,” International Journal of Infectious Diseases, vol. 20, no. 1, pp. 13–17, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. D. Hoppensteadt, K. Tsuruta, J. Hirman, I. Kaul, Y. Osawa, and J. Fareed, “Dysregulation of inflammatory and hemostatic markers in sepsis and suspected disseminated intravascular coagulation,” Clinical and Applied Thrombosis/Hemostasis, vol. 21, no. 2, pp. 120–127, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. C. T. Esmon, “The interactions between inflammation and coagulation,” British Journal of Haematology, vol. 131, no. 4, pp. 417–430, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. M. P. Fink, “Editorial: hemopexin: newest member of the anti-inflammatory mediator club,” Journal of Leukocyte Biology, vol. 86, no. 2, pp. 203–204, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Y. Jung, Y. H. Kwak, K. S. Kim, W. Y. Kwon, and G. J. Suh, “Change of hemopexin level is associated with the severity of sepsis in endotoxemic rat model and the outcome of septic patients,” Journal of Critical Care, vol. 30, no. 3, pp. 525–530, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Traegera, M. Mikulcakb, C. Eipelc et al., “Kupffer cell depletion reduces hepatic inflammation and apoptosis but decreases survival in abdominal sepsis,” European Journal of Gastroenterology & Hepatolog, vol. 22, no. 9, pp. 1039–1049, 2010. View at Publisher · View at Google Scholar
  42. K. R. Kasten, J. T. Muenzer, and C. C. Caldwell, “Neutrophils are significant producers of IL-10 during sepsis,” Biochemical and Biophysical Research Communications, vol. 393, no. 1, pp. 28–31, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. D. J. Berg, R. Kuhn, K. Rajewsky et al., “Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance,” The Journal of Clinical Investigation, vol. 96, no. 5, pp. 2339–2347, 1995. View at Publisher · View at Google Scholar · View at Scopus
  44. G. Y. Song, C.-S. Chung, I. H. Chaudry, and A. Ayala, “What is the role of interleukin 10 in polymicrobial sepsis: anti-inflammatory agent or immunosuppressant?” Surgery, vol. 126, no. 2, pp. 378–383, 1999. View at Publisher · View at Google Scholar · View at Scopus